しびれが診える　エキスパートのアプローチ

出版社： 中外医学社
著者：
発行日： 2020-04-15
分野： 臨床医学：内科  >  脳神経科学/神経内科学
ISBN： 9784498328501
電子書籍版： 2020-04-15 （1版1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

4,620 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

4,620 円(税込)

購入する

商品紹介

Commonな訴えのひとつであるしびれ感．一見単純だが実は複雑な症状のため，アプローチに難渋することがあるのではないだろうか．本書では、部位による鑑別診断を整理し，各領域のエキスパートが，しびれ感の正確な理解と適切な対応を解説した．日常診療に役立つ知識が網羅された充実の一冊だ．

目次

  • A　しびれ感総論
    　1．しびれ感の意味と意義　
    　2．しびれ感の原因とその出現機序（しびれ感出現の機序について）　
    　3．しびれ感を呈する疾患　
    　4．しびれ感発症の解剖と病態生理　　
    　5．しびれ感の評価　

    B　主要疾患としびれ感，その対応
    　1．脳血管障害
    　2．脊髄腫瘍・脊髄血管障害
    　3．脊髄空洞症
    　4．多発性硬化症／視神経脊髄炎および脊髄炎
    　5．パーキンソン病
    　6．ALS
    　7．糖尿病性ニューロパチー
    　8．GBS／CIDP／抗MAG抗体関連ニューロパチー　
    　9．Small fiber neuropathy　
    　10．遺伝性ニューロパチー
    　11．アミロイドニューロパチー

    C　部位によるしびれ感とその対応
    　顔面
    　　1．三叉神経障害
    　上肢
    　　2．頸椎疾患（頸椎神経根症，頸椎症性脊髄症）
    　　3．腕神経叢障害
    　　4．圧迫性（絞扼性）ニューロパチー　
    　下肢
    　　5．腰椎疾患
    　　6．圧迫性（絞扼性）ニューロパチー（外側大腿皮神経痛，
    　　　　梨状筋症候群，大腿神経絞扼障害，閉鎖神経症候群，他）
    　　7．下腿を中心としたしびれ感（伏在神経障害，腓骨神経障害，
    　　　　　浅腓骨神経障害，外側腓腹皮神経障害）　
    　　8．足を中心としたしびれ感（前足根管症候群，モートン神経腫，足根管症候群）
    　　9．Restless legs症候群　

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

A しびれ感総論

P.11 掲載の参考文献
1) Colfer A, editor. Paresthesia : a revised and updated study. New Jersey : Foster Academics ; 2015.
 
2) 日本神経治療学会, 監. 福武敏夫, 安藤哲朗, 冨本秀和, 編. 標準的神経治療 しびれ感. 医学書院 ; 2017.
 
3) Remmel K, Bunyan R, Brumback R, et al. Handbook of symptom-oriented neurology 3rd ed. St Louis : Mosby ; 2002.
 
4) 福武敏夫. 神経症状の診かた・考えかた-General Neurology のすすめ 第2版. 医学書院 ; 2017.
 
5) 牧村史陽, 編. 大阪ことば事典. 講談社 ; 1984.
 
6) 南山堂医学大辞典 第20版. 南山堂 ; 2015.
 
7) 日本神経学会用語委員会, 編. 神経学用語集 改訂第3版. 文光堂 ; 2008.
 
8) William Pryse-Phillips. Companion to clinical neurology 3rd ed. Oxford : Oxford University Press ; 2009.
 
9) Campbell WW. DeJong's The neurologic examination 7th ed. Philadelphia : Wolters Kluwer ; 2013.
 
10) Ropper AH, Samuels MA, Klein JP. Adams and Victor's principles of neurology 10th ed. New York : McGraw-Hill ; 2014.
 
11) 福武敏夫. 脊髄臨床神経学ノート. 三輪書店 ; 2014.
 
12) 平山惠造, 得丸幸夫, 坪井義夫, 他. 変形性頚椎症の神経障害と臨床病型-108例の分析. 神経進歩. 1993 ; 37 : 213-25.
 
13) 桑原聡. しびれ感の解剖・生理学. 日本神経治療学会, 監. 福武敏夫, 安藤哲朗, 冨本秀和, 編. 標準的神経治療 しびれ感. 医学書院 ; 2017. p.11-6.
 
14) Jaaskelainen SK, Woda A. Burning mouth syndrome. Cephalalgia. 2017 ; 37 : 627-47.
PubMed
15) Muto M, Mori M, Sato Y, et al. Current symptomatology in multiple sclerosis and neuromyelitis optica. Eur J Neurol. 2015 ; 22 : 299-304.
PubMed
16) Peralta CM, Frauscher B, Seppi K, et al. Restless legs syndrome in Parkinson's disease. Mov Disord. 2009 ; 24 : 2076-80.
PubMed
17) 渡辺宏久, 勝野雅央, 祖父江元. Parkinson 病のしびれ感. 日本神経治療学会, 監. 福武敏夫, 安藤哲朗, 冨本秀和, 編. 標準的神経治療 しびれ感. 医学書院 ; 2017. p.63-6.
 
18) 兼本浩祐. てんかん学ハンドブック 第3版. 医学書院 ; 2012.
 
19) Prakash S, Rathore C, Makwana P, et al. Recurrent spontaneous paresthesia in the upper limb could be due to migraine : a case series. Headache. 2015 ; 55 : 1143-7.
 
20) 福武敏夫. しびれ (感) の概念としびれ (感) をきたす原因・病態・疾患. 日本神経治療学会, 監. 福武敏夫, 安藤哲朗, 冨本秀和, 編. 標準的神経治療 しびれ感. 医学書院 ; 2017. p.1-10.
 
P.21 掲載の参考文献
1) 日本神経学会用語委員会, 編. 神経学用語集 改訂第3版. 文光堂 ; 2008.
 
2) Lennertz RC, Tsunozaki M, Bautista DM, et al. Physiological basis of tingling paesthesia evoked by hydroxyl-α-sanshool. J Neurosci. 2010 ; 30 : 4353-61.
 
3) Maksimovic S, Nakatani M, Baba Y, et al. Epidermal Merkel cells are mechanosensory cells that tune mammalian touch receptors. Nature. 2014 ; 509 : 617-21.
PubMed
4) Mogyoros I, Bostock H, Burke D. Mechanisms of paresthesias arising from healthy axons. Muscle Nerve. 2000 ; 23 : 310-20.
PubMed
5) Bernhardt M. Neuropathologische Beobachtungen. Deutsches Archiv fur Klinische Medicin. Leipzig. 1878 ; 22 : 362-93.
 
6) Roth WK. Meralgia paresthetica. Berlin, Karger ; 1895.
 
7) Bernhardt M. Ueber isoliert im Gebiete des N. cutaneous femoris extenus vorkommende Paraesthesien. Neurol Centralblatt. 1895 ; 14 : 242-4.
 
8) Wartenberg R. Neuritis, sensory neuritis, and neuralgia. New York : Oxford Press ; 1958. p.179-83, 206-32.
 
9) Astwazaturow M. Uberparesthetische Neuralgia und eine besondere Form derselben-Notalgia paresthetica. Deutsche Zeitschr f. Nervenheilk. 1934 ; 133 : 188.
 
10) Massey EW, Pleet AB. Electromyographic evaluation of notalgia paresthetica. Neurology. 1981 ; 31 : 642.
PubMed
11) Sittig O. Klinische Beitrage zur Lehre von der Lokalisation der sensiblen Rindenzentren. Prager Med Wochenschr. 1914 ; 45 : 548-50.
 
12) Garcin R, Lapresle J. Deuxieme observation personnelle de syndrome sensitif de type thalamique et a topographie cheiro-orale par lesion localisee du thalamus. Rev Heurol (Paris). 1960 ; 103 : 474-81.
 
13) Vallbo AB, Hagbarth KE. Activity from skin mechanoreceptors recorded percutaneously in awake human subjects. Exper Neurol. 1968 ; 3 : 486-500.
 
14) Ochoa JL, Torebjork. Paresthesia from ectopic impulse generation in human sensory nerves. Brain. 1980 ; 103 : 835-53.
PubMed
15) Merrington WR, Nathan PW. A study of post-ischaemic paraesthesiae. J Neurol Neurosurg Psychiat. 1949 ; 12 : 1-18.
PubMed
P.32 掲載の参考文献
1) 高橋愼一. しびれ感を呈する疾患. Clin Neurosci. 2018 ; 36 : 420-4.
 
2) 日本神経治療学会, 監. 福武敏夫, 安藤哲朗, 冨本秀和, 編. 標準的神経治療 しびれ感. 医学書院 ; 2017.
 
3) 高橋愼一. 全身診察法. medicina. 2014 ; 51 : 1202-4.
 
4) 高橋愼一. 感覚障害の神経学的検査. Clin Neurosci. 2015 ; 35 : 539-42.
 
5) 平山惠造. 神経症候学 (改訂第二版) I・II. 文光堂 ; 2010.
 
6) 鈴木則宏, 編. 神経診察クローズアップ. メジカルビュー社 ; 2011.
 
7) 後藤文男, 天野隆弘. 臨床のための神経機能解剖学. 中外医学社 ; 1992.
 
8) 岩田誠. 神経症候学を学ぶ人のために. 医学書院 ; 1994.
 
P.40 掲載の参考文献
1) 神田隆. 神経学を学ぶ前に知っておかねばならないこと. 医学生・研修医のための神経内科学. 中外医学社 ; 2008. p.7-8.
 
2) 桑原聡. しびれ感の解剖・生理学. 福武敏夫, 安藤哲朗, 冨本秀和, 編. 標準的治療 しびれ感. 医学書院 ; 2017. p.11-6.
 
3) 感覚障害の診かた. 田崎義昭, 斉藤佳雄, 編. ベッドサイドの神経の診かた 第15版. 南山堂 ; 1994. p.187-94.
 
P.50 掲載の参考文献
1) 日本神経学会用語委員会, 編. 神経学用語集 改訂第3版. 2008. 凡例 15-16.
 
2) Pryse-Phillips WE. Validation of a diagnostic sign in carpal tunnel syndrome. J Neurol Neurosurg Psychiatry. 1984 ; 47 : 870-2.
PubMed
3) Stevens JC, Smith BE, Weaver AL, et al. Symptoms of 100 patients with electromyographically verified carpal tunnel syndrome. Muscle Nerve. 1999 ; 22 : 1448-56.
PubMed
4) Tanaka Y, Kokubun S, Sato T, et al. Cervical roots as origin of pain in the neck or scapular regions. Spine. 2006 ; 31 : E568-73.
PubMed
5) Waxman SG. The flexion-adduction sign in neuralgic amyotrophy. Neurology. 1979 ; 29 : 1301-4.
PubMed
6) Dyck P, Doyle JB Jr." Bicycle test"of van Gelderen in diagnosis of intermittent cauda equina compression syndrome. Case report. J Neurosurg. 1977 ; 46 : 667-70.
 
7) 園生雅弘. 手のしびれ : myelopathy/radiculopathyとneuropathy. MB Orthop. 2016 ; 29 : 13-9.
 
8) Kuwabara S, Ogawara K, Koga M, et al. Hyperreflexia in Guillain-Barre syndrome : relation with acute motor axonal neuropathy and anti-GM1 antibody. J Neurol Neurosurg Psychiatry. 1999 ; 67 : 180-4.
PubMed
9) Chiba T, Konoeda F, Higashihara M, et al. C8 and T1 innervation of forearm muscles. Clin Neurophysiol. 2015 ; 126 : 637-42.
 
10) 園生雅弘. MMT・針筋電図ガイドブック. 中外医学社 ; 2018.
 
11) 園生雅弘. 頸椎症性筋萎縮症. Brain Nerve. 2016 ; 68 : 509-19.
 
12) 園生雅弘. ヒステリー (転換性障害) の神経学. Brain Nerve. 2014 ; 66 : 863-71.
 
13) Michel F, Decavel P, Toussirot E, et al. The piriformis muscle syndrome : an exploration of anatomical context, pathophysiological hypotheses and diagnostic criteria. Ann Phys Rehabil Med. 2013 ; 56 : 300-11.
PubMed
14) 園生雅弘. 胸郭出口症候群. Brain Nerve. 2014 ; 66 : 1429-39.
 
15) Nakashima H, Yukawa Y, Suda K, et al. Abnormal findings on magnetic resonance images of the cervical spines in 1211 asymptomatic subjects. Spine. 2015 ; 40 : 392-8.
PubMed
16) 園生雅弘. 脊椎脊髄疾患の電気診断学. 脊髄機能診断学. 2011 ; 33 : 1-7.
 
17) Aranyi Z, Csillik A, Devay K, et al. Ultrasonographic identification of nerve pathology in neuralgic amyotrophy : Enlargement, constriction, fascicular entwinement, and torsion. Muscle Nerve. 2015 ; 52 : 503-11.
PubMed
18) 園生雅弘. 神経筋の電気診断. Brain Nerve. 2007 ; 59 : 241-50.
 
19) 小林祥泰, 内尾祐司, 桑原聡, 他. 標準的神経治療 : 手根管症候群 (CTS). 神経治療学. 2008 ; 25 : 63-84.
 
20) Czyrny JJ, Lawrence J. Importance of paraspinal muscle electromyography in cervical and lumbosacral radiculopathies : a commentary. Am J Phys Med Rehabil. 1995 ; 74 : 458-9.
 

B 主要疾患としびれ感, その対応

P.66 掲載の参考文献
1) Bowsher D. Central pain : Clinical and physiological characteristics. J Neurol Neurosurg Psychiatry. 1996 ; 61 : 62-9.
PubMed
2) Andersen G, Vestergaard K, Ingeman-Nielsen M, et al. Incidence of central post-stroke pain. Pain. 1995 ; 61 : 187-93.
PubMed
3) Bowsher D. Stroke and central poststroke pain in an elderly population. J Pain. 2001 ; 2 : 258-61.
 
4) Bogousslavsky J, Regli F, Uske A. Thalamic infarcts : Clinical syndromes, etiology, and prognosis. Neurology. 1988 ; 38 : 837-48.
PubMed
5) MacGowan DJ, Janal MN, Clark WC, et al. Central poststroke pain and Wallenberg's lateral medullary infarction : Frequency, character, and determinants in 63 patients. Neurology. 1997 ; 49 : 120-5.
 
6) Leijon G, Boivie J, Johansson I. Central post-stroke pain--neurological symptoms and pain characteristics. Pain. 1989 ; 36 : 13-25.
PubMed
7) Kumral E, Kocaer T, Ertubey NO, et al. Thalamic hemorrhage. A prospective study of 100 patients. Stroke. 1995 ; 26 : 964-70.
PubMed
8) Bogousslavsky J, Maeder P, Regli F, et al. Pure midbrain infarction : clinical syndromes, MRI, and etiologic patterns. Neurology. 1994 ; 44 : 2032-40.
PubMed
9) Derry S, Bell RF, Straube S, et al. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev. 2019 ; 1 : CD007076.
PubMed
P.75 掲載の参考文献
1) 岩田誠. 神経症候学を学ぶ人のために. 医学書院 ; 1994. p.287-92.
 
2) 後藤文男, 天野隆弘. 臨床のための神経機能解剖学. 中外医学社 ; 1992. p.136-51.
 
3) Kanchandani R, Howe JG. Lhermitte's sign in multiple sclerosis : a clinical survey and review of the literature. J Neurol Neurosurg Psychiatry. 1982 ; 45 : 308-12.
 
4) Duong LM, McCarthy BJ, McLendon RE, et al. Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004-2007. Cancer. 2012 ; 118 : 4220-7.
PubMed
5) 平野健一, 今釜史郎, 石黒直樹. 原発性脊髄腫瘍の疫学. 健康管理事業団研究助成論文集. 2012 ; 28 : 41-7.
 
6) Shrivastava RK, Epstein FJ, Perin NI, et al. Intramedullary spinal cord tumors in patients older than 50 years of age : management and outcome analysis. J Neurosurg Spine. 2005 ; 2 : 249-55.
PubMed
7) Waldron JN, Laperriere NJ, Jaakkimainen L, et al. Spinal cord ependymomas : a retrospective analysis of 59 cases. Int J Radiat Oncol Biol Phys. 1993 ; 27 : 223-9.
PubMed
8) Weber DC, Wang Y, Miller R, et al. Long-term outcome of patients with spinal myxopapillary ependymoma : treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network. Neuro Oncol. 2015 ; 17 : 588-95.
 
9) Levy WJ, Latchaw J, Hahn JF, et al. Spinal neurofibromas : a report of 66 cases and a comparison with meningiomas. Neurosurgery. 1986 ; 18 : 331-4.
 
10) Klekamp J, Samii M. Surgery of spinal nerve sheath tumors with special reference to neurofibromatosis. Neurosurgery. 1998 ; 42 : 279-89.
PubMed
11) Saiki M, Taguchi T, Kaneko K, et al. Measuring of the compensation of a nerve root in a cervical schwannoma : a case report. J Orthop Sci. 2003 ; 8 : 714-6.
 
12) Cole JS, Patchell RA. Metastatic epidural spinal cord compression. Lancet Neurol. 2008 ; 7 : 459-66.
PubMed
13) Bach F, Larsen BH, Rohde K, et al. Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression. Acta Neurochir. 1990 ; 107 : 37-43.
PubMed
14) Helweg-Larsen S, Sorensen PS. Symptoms and signs in metastatic spinal cord compression : a study of progression from first symptom until diagnosis in 153 patients. Eur J Cancer. 1994 ; 30 : 396-8.
 
15) DeAngelis LM, Posner JB. Neurologic complications of cancer. Oxford University Press ; 2008. p.203-8.
 
16) Robertson CE, Brown RD Jr, Wijdicks EF, et al. Recovery after spinal cord infarcts : long-term outcome in 115 patients. Neurology. 2012 ; 78 : 114-21.
PubMed
17) 桑山直也. 脊髄動静脈シャント疾患の分類. 脊椎脊髄ジャーナル. 2011 ; 24 : 244-9.
 
18) Burchiel KJ, Hsu FP. Pain and spasticity after spinal cord injury : mechanisms and treatment. Spine. 2001 ; 26 : S146-60.
PubMed
P.88 掲載の参考文献
1) 厚東篤生. 脊髄空洞症の発生病理. 神経内科. 1985 ; 23 : 1-7.
 
2) Gardner WJ. Hydrodynamic mechanism of syringomyelia : its relationship to myelocele. J Neurol Neurosurg Psychiatry. 1965 ; 28 : 247-59.
PubMed
3) Williams B. Pathogenesis of syringomyelia. Lancet. 1972 ; 2 : 969-70.
PubMed
4) Williams B. Progress in syringomyelia. Neurol Res. 1986 ; 8 : 130-45.
PubMed
5) Fischbein NJ, Dillon WP, Cobbs C, et al. The "presyrinx" state : a reversible myelopathic condition that may precede syringomyelia. AJNR Am J Neuroradiol. 1999 ; 20 : 7-20.
 
6) Schievink WI, Maya MM. Hemodialysis headache and presyrinx in spontaneous intracranial hypotension. Neurology. 2010 ; 75 : 1847-9.
PubMed
7) Barnett HJM, Foster JB, Hudgson P. Syringomyelia. London : W. B. Saunders ; 1973.
 
8) Logue V. 14th crookshank lecture syringomyelia : a radiodiagnostic and radiotherapeutic saga. Clin Radiol. 1971 ; 22 : 2-16.
PubMed
9) Williams B. The distending force in the production of communicating syringomyelia. Lancet. 1969 ; 2 : 696.
PubMed
10) 厚生労働省. 脊髄空洞症 (指定難病117). 難病情報センター ; 2019. Available from : http://www.nanbyou.or.jp/entry/283
 
11) Moriwaka F, Tashiro K, Tachibana S, et al. [Epidemiology of syringomyelia in Japan--the nationwide survey]. Rinsho Shinkeigaku. 1995 ; 35 : 1395-7.
PubMed
12) Sakushima K, Tsuboi S, Yabe I, et al. Nationwide survey on the epidemiology of syringomyelia in Japan. J Neurol Sci. 2012 ; 313 : 147-52.
PubMed
13) 矢部一郎, 佐々木秀直. 脊髄空洞症. 神経治療学. 2017 ; 34 : 346-9.
Medical*Online
14) Patten J. PATTEN神経診断学. 後藤文男, 監訳. 中外医学社 ; 1984.
 
15) Netsky MG. Syringomyelia ; a clinicopathologic study. AMA Arch Neurol Psychiatry. 1953 ; 70 : 741-77.
PubMed
16) 後藤文男, 天野隆弘. 臨床のための神経機能解剖学. 中外医学社 ; 1992.
 
17) Francis McGlone, Wessberg J, Olausson H. Discriminative and affective touch : sensing and feeling. Neuron. 2014 ; 82 : 737-55.
PubMed
18) 野川茂. 複合感覚. Clin Neurosci. 2015 ; 33 : 531-4.
 
19) 向井栄一郎. 脊髄空洞症の神経症候. 神経内科. 1985 ; 23 : 8-15.
 
20) Honan WP, Williams B. Sensory loss in syringomyelia : not necessarily dissociated. J R Soc Med. 1993 ; 86 : 519-20.
 
21) 岩崎喜信, 阿部弘, 井須豊彦, 他. Syringomyeliaの診断と病態像の検討. 脳と神経. 1984 ; 36 : 137-42.
 
22) 野川茂, 小原克之, 鈴木則宏, 他. 運動ニューロン疾患を思わせた脊髄空洞症の1例. 臨床神経学. 1987 ; 27 : 678-9.
 
23) 向井栄一郎, 五藤進一朗, 高橋昭, 他. 脊髄空洞症の臨床. 神経内科. 1983 ; 19 : 477-83.
 
P.97 掲載の参考文献
1) 桑原聡. 標準的神経治療 しびれ感. 医学書院 ; 2017. p.11-5.
 
2) Neugebauer V, Galhardo V, Maione S, et al. Forebrain pain mechanisms. Brain Res Rev. 2009 ; 60 : 226-42.
PubMed
3) Araki M, Matsuoka T, Miyamoto K, et al. Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica : a pilot study. Neurology. 2014 ; 82 : 1302-6.
PubMed
4) 下島恭弘, 池田修一. 多発性硬化症. 綜合臨牀. 2006 ; 55 : 2281-6.
Medical*Online
5) Beiske AG, Pedersen ED, Czujko B, et al. Pain and sensory complaints in multiple sclerosis. Eur J Neuol. 2004 ; 11 : 479-82.
 
6) Osterberg A, Boivie J, Thuomas KA. Central pain in multiple sclerosis-prevalence and clinical characteristics. Eur J Pain. 2006 ; 9 : 531-42.
 
7) Kratz AL, Ehde DM, Hanley MA, et al. Cross-sectional examination of the associations between symptoms, community integration, and mental health in multiple sclerosis. Arch Phys Med Rehabil. 2016 ; 97 : 386-94.
PubMed
8) 菊地誠志. 多発性硬化症によるしびれ・痛みをどう診るか. medicina. 2008 ; 45 : 289-92.
 
9) 柴崎浩, 他. 多発性硬化症全国症例調査成績. 厚生省特定疾患免疫性疾患調査研究班, 平成2年度研究報告書. 1990. p.93-9.
 
10) Smith KJ. McDonald WI. The pathophysiology of multiple sclerosis : the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci. 1999 ; 354 : 1649-73.
PubMed
11) 河野優, 井上聖啓. 多発性硬化症と痒み. 神経内科. 2003 ; 58 : 42-7.
 
12) Guthrie TC, Nelson DA. Influence of temperature changes on multiple sclerosis : critical review of mechanisms and research potential. J Neurol Sci. 1995 ; 129 ; 1-8.
PubMed
13) Kanamori Y, Nakashima I, Takai Y, et al. Pain in neuromyelitis optica and its effect on quality of life : a cross-sectional study. Neurology. 2011 ; 77 : 652-8.
PubMed
14) Borchers AT, Gershwin ME. Transverse myelitis. Autoimmune Rev. 2012 ; 11 : 231-48.
PubMed
15) 藤盛寿一, 中島一郎. 多発性硬化症の診断・治療の進展 多発性硬化症治療の現状と将来展望. 日本医事新報. 2018 ; 4912 : 41-6.
 
16) 日本神経学会, 監. 「多発性硬化症・視神経脊髄炎診療ガイドライン」作成委員会, 編. 多発性硬化症・視神経脊髄炎診療ガイドライン 2017. 医学書院 ; 2017. p.267-8.
 
17) Chitsaz A, Janghorbani M, Shaygannejad V, et al. Sensory complaints of the upper extremities in multiple sclerosis : relative efficacy of nortriptyline and transcutaneous electrical nerve stimulation. Clin J Pain. 2009 ; 25 : 281-5.
PubMed
18) Vollmer TL, Robinson MJ, Risser RC, et al. A randomized, double-blind, placebo-controlled trial of duloxetine for the treatment of pain in patients with multiple sclerosis. Pain Pract. 2014 ; 14 : 732-44.
PubMed
19) Rossi S, Mataluni G, Codeca C, et al. Effects of levetiracetam on chronic pain in multiple sclerosis : results of a pilot, randomized, placebo-controlled study. Eur J Neurol. 2009 ; 16 : 360-6.
PubMed
20) Solaro C, Brichetto G, Battaglia MA, et al. Antiepileptic medications in multiple sclerosis : adverse effects in a three-year follow-up study. Neurol Sci. 2005 ; 25 : 307-10.
 
P.107 掲載の参考文献
1) Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015 ; 30 : 1591-601.
PubMed
2) 日本神経学会, 監. 「パーキンソン病診療ガイドライン」作成委員会, 編. 序章 パーキンソン病とは 1. パーキンソン病の診断, パーキンソン病診療ガイドライン 2018. 医学書院 ; 2018. p.2-3.
 
3) Koller W. Sensory symptoms in Parkinson's disease. Neurology. 1984 ; 34 : 957-9.
PubMed
4) Bayulkem K, Lopez G. Clinical approach to nonmotor sensory fluctuations in Parkinson's disease. J Neurol Sci. 2011 ; 310 : 82-5.
PubMed
5) Snider SR, Fahn S, Isgreen WP, et al. Primary sensory symptoms in parkinsonism. Neurology. 1976 ; 26 : 423-9.
PubMed
6) 日本神経学会, 監. 「パーキンソン病診療ガイドライン」作成委員会, 編. 第III編 パーキンソン病診療に関する Q&A, パーキンソン病診療ガイドライン 2018. 医学書院 ; 2018. p.272-3.
 
7) Djaldetti R, Shifrin A, Rogowski Z, et al. Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology. 2004 ; 62 : 2171-5.
PubMed
8) Broen MPG, Braaksma MM, Patijn J, et al. Prevalence of pain in Parkinson's disease : a systematic review using the modified QUADAS tool. Mov Disord. 2012 ; 27 : 480-4.
PubMed
9) Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, et al. The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals : An international study using the nonmotor symptoms questionnaire. Mov Disord. 2010 ; 25 : 704-9.
 
10) Kubo SI, Hamada S, Maeda T, et al. A Japanese multicenter survey characterizing pain in Parkinson's disease. J Neurol Sci. 2016 ; 365 : 162-6.
 
11) Chaudhuri KR, Rizos A, Trenkwalder C, et al. King's Parkinson's disease pain scale, the first scale for pain in PD : an international validation. Mov Disord. 2015 ; 30 : 1623-31.
 
12) Ford B. Pain in Parkinson's disease. Clin Neurosci. 1998 ; 5 : 63-72.
PubMed
13) Ford B. Pain in Parkinson's disease. Mov Disord. 2010 ; 25 (Suppl 1) : S98-103.
 
14) Wasner G, Deuschl G. Pains in Parkinson disease-many syndromes under one umbrella. Nat Rev Neurol. 2012 ; 8 : 284-94.
PubMed
15) 吉井文均. Parkinson病の疼痛 : 最近の話題から. 神経内科. 2017 ; 86 : 205-14.
 
16) Broetz D, Eichner M, Gasser T, et al. Radicular and nonradicular back pain in Parkinson's disease : a controlled study. Mov Disord. 2007 ; 22 : 853-6.
PubMed
17) Takeda R, Ikeda T, Tsuda F, et al. Unilateral lesions of mesostriatal dopaminergic pathway alters the withdrawal response of the rat hindpaw to mechanical stimulation. Neurosci Res. 2005 ; 52 : 31-6.
PubMed
18) Wood PB. Role of central dopamine in pain and analgesia. Expert Rev Neurother. 2008 ; 8 : 781-97.
PubMed
19) 曽我部昌一, 川上順子. ドパミンシステムによる痛みの修飾. Front Park Dis. 2011 ; 4 : 18-22.
 
20) 渡邊和之, 紺野愼一. 慢性腰痛と側坐核. Clin Neurosci. 2018 ; 36 : 1454-6.
 
21) Scherder E, Wolters E, Polman C, et al. Pain in Parkinson's disease and multiple sclerosis : Its relation to the medial and lateral pain systems. Neurosci Biobehav Rev. 2005 ; 29 : 1047-56.
 
22) Brefel-Courbon C, Payoux P, Thalamas C, et al. Effects of levodopa on pain threshold in Parkinson's disease : a clinical and positron emission tomography study. Mov Disord. 2005 ; 20 : 1557-63.
PubMed
23) Nolano M, Provitera V, Manganelli F, et al. Loss of cutaneous large and small fibers in naive and l-dopa-treated PD patients. Neurology. 2017 ; 89 : 776-84.
PubMed
24) Quinn NP, Lang AE, Koller WC, et al. Painful Parkinson's disease. Lancet. 1986 ; 327 : 1366-9.
 
25) Kassubek J, Chaudhuri KR, Zesiewicz T, et al. Rotigotine transdermal system and evaluation of pain in patients with Parkinson's disease : a post hoc analysis of the RECOVER study. BMC Neurol. 2014 ; 14 : 42.
PubMed
26) Sage J. Pain in Parkinson's disease. Curr Treat Options Neurol. 2004 ; 6 : 191-200.
PubMed
27) Indaco A, Carrieri PB. Amitriptyline in the treatment of headache in patients with Parkinson's disease : a double-blind placebo-controlled study. Neurology. 1988 ; 38 : 1720-2.
PubMed
28) Witjas T, Kaphan E, Regis J, et al. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Mov Disord. 2007 ; 22 : 1729-34.
PubMed
29) Seppi K, Ray Chaudhuri K, Coelho M, et al. Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review. Mov Disord. 2019 ; 34 : 180-98.
PubMed
30) Trenkwalder C, Chaudhuri KR, Martinez-Martin P, et al. Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA) : a double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2015 ; 14 : 1161-70.
 
31) Rascol O, Zesiewicz T, Chaudhuri KR, et al. A randomized controlled exploratory pilot study to evaluate the effect of rotigotine transdermal patch on Parkinson's Disease-Associated Chronic Pain. J Clin Pharmacol. 2016 ; 56 : 852-61.
PubMed
32) Cattaneo C, Barone P, Bonizzoni E, et al. Effects of safinamide on pain in fluctuating Parkinson's disease patients : a post-hoc analysis. J Parkinsons Dis. 2017 ; 7 : 95-101.
PubMed
P.113 掲載の参考文献
1) Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci. 1994 ; 124 Suppl : 96-107.
 
2) Brooks BR, Miller RG, Swash M, et al. El Escorial revisited : revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 ; 1 : 293-9.
 
3) de Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008 ; 119 : 497-503.
PubMed
4) Hammad M, Silva A, Glass J, et al. Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology. 2007 ; 69 : 2236-42.
PubMed
5) Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995 ; 118 : 707-19.
 
6) Kothari MJ, Rutkove SB, Logigian EL, et al. Coexistent entrapment neuropathies in patients with amyotrophic lateral sclerosis. Arch Phys Med Rehabil. 1996 ; 77 : 1186-8.
PubMed
7) Traynor BJ, Codd MB, Corr B, et al. Amyotrophic lateral sclerosis mimic syndromes : a population-based study. Arch Neurol. 2000 ; 57 : 109-13.
PubMed
8) Kawamura Y, Dyck PJ, Shimono M, et al. Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 1981 ; 40 : 667-75.
PubMed
9) Bradley WG, Good P, Rasool CG, et al. Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis. Ann Neurol. 1983 ; 14 : 267-77.
PubMed
10) Isaacs JD, Dean AF, Shaw CE, et al. Amyotrophic lateral sclerosis with sensory neuropathy : part of a multisystem disorder? J Neurol Neurosurg Psychiatry. 2007 ; 78 : 750-3.
PubMed
11) Iglesias C, Sangari S, El Mendili MM, et al. Electrophysiological and spinal imaging evidences for sensory dysfunction in amyotrophic lateral sclerosis. BMJ Open. 2015 ; 5 : e007659.
PubMed
12) Weis J, Katona I, Muller-Newen G, et al. Small-fiber neuropathy in patients with ALS. Neurology. 2011 ; 76 : 2024-9.
PubMed
13) Dalla Bella E, Lombardi R, Porretta-Serapiglia C, et al. Amyotrophic lateral sclerosis causes small fiber pathology. Eur J Neurol. 2016 ; 23 : 416-20.
PubMed
14) Nishiyama A, Warita H, Takahashi T, et al. Prominent sensory involvement in a case of familial amyotrophic lateral sclerosis carrying the L8V SOD1 mutation. Clin Neurol Neurosurg. 2016 ; 150 : 194-6.
 
15) Marjanovic IV, Selak-Djokic B, Peric S, et al. Comparison of the clinical and cognitive features of genetically positive ALS patients from the largest tertiary center in Serbia. J Neurol. 2017 ; 264 : 1091-8.
PubMed
P.123 掲載の参考文献
1) Thomas PK. Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes. 1993 ; 46 (Suppl 2) : S54-57.
 
2) Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies : update on definitions, diagnostic criteria, estimateon of severity, and treatments. Diabetes Care. 2010 ; 33 : 2285-93.
 
3) 水上浩哉. 糖尿病性神経障害の成因とその治療. Diabetes Frontier. 2015 ; 26 : 460-5
 
4) Smith AG, Russell J, Feldman EL, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006 ; 29 : 1294-9.
PubMed
5) 鈴木千恵子. 糖尿病性神経障害. 神経治療. 2018 ; 35 : 284-7.
Medical*Online
6) 出口尚寿, 西尾善彦, 高嶋博. 糖尿病と自己免疫性ニューロパチー. Brain Nerve. 2014 ; 66 : 135-47.
 
7) Kelkar P, Masood M, Parry JG. Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology. 2000 ; 55 : 83-8.
 
8) Said G, Lacroix C, Lozeron P, et al. Inflammatory vasculopathy in multifocal diabetic neuropathy. Brain. 2003 ; 126 : 376-85.
PubMed
9) 神田隆. 糖尿病性神経障害の病理. 日本臨牀. 2005 ; 63 : 482-7.
Medical*Online
10) Bradley JL, Thomas PK, King RHM, et al. A comparison of perineurial and vascular basal laminal changes in diabetic neuropathy. Acta Neuropathol. 1994 ; 88 : 426-32.
 
11) Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus. N Engl J Med. 1993 ; 329 : 977-86.
 
12) Hotta N, Kawamori R, Fukuda M, et al. Lomg-term clinical effets of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complocations : multivariate spidemiological analysis based on patient background factors and severity of diabetic neuropathy. Diabet Med. 2012 ; 29 : 1529-33.
 
13) Danis RP, Sheetz MJ. Ruboxistaurin : PKC-beta inhibition for complication of diabetes. Expert Opin Pharmacother. 2009 ; 10 : 2913-25.
PubMed
14) Goh SY, Cooper ME. Clinical review : the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 2008 ; 93 : 1143-52.
PubMed
15) Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alphalipoic acid improves symptomatic diabetic polyneuropathy : the SYDNEY 2 trial. Diabetes Care. 2006 ; 29 : 2365-70.
PubMed
16) Himeno T, Kamiya H, Naruse K, et al. Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice. Diabetes. 2011 ; 60 : 2397-406.
PubMed
17) Tesfaye S, Vileikyte L, Rayman G, et al. Painful diabetic peripheral neuropathy : consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev. 2011 ; 27 : 629-38.
PubMed
18) Yasuda H, Hotta N, Nakao K, et al. Superiority of duloxetine to placebo in improveing diabetic neuropathic pain : Results of a randomized controlled trial in Japan. J Diabetes Investig. 2011 ; 2 : 132-9.
 
19) Satoh J, Yagihashi S, Baba M, et al. Efficacy and safety evaluation of pregaballin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial. J Diabetes Investig. 2011 ; 2 : 457-63.
 
P.133 掲載の参考文献
1) 寒川真, 楠進. Guillain-Barre症候群. Clin Neurosci. 2018 ; 36 : 1035-8.
 
2) 小池春樹. ジカウイルスとギラン・バレー症候群. Brain Nerve. 2018 ; 70 : 113-20.
 
3) 寒川真, 楠進. Guillain-Barre症候群の疫学・症状と神経症候. 日本臨牀. 2015 ; 1085 : 367-73.
 
4) 小池春樹. Guillain-Barre症候群・慢性炎症性脱髄性多発根神経炎. 標準的治療 しびれ感. 医学書院 ; 2017. p.87-90
 
5) Ruts L, Drenthen J, Jongen JL, et al. Dutch GBS Study Group. Pain in Guillain-Barre syndrome : a long-term follow-up study. Neurology. 2010 ; 75 : 1439-47.
 
6) Ang CW, Tio-Gillen AP, Groren J, et al. Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barre syndrome. J Neuroimmunol. 2002 ; 130 : 179-83.
 
7) Samukawa M, Hamada Y, Kuwahara M, et al. Clinical features in Guillain-Barre syndrome with anti-Gal-C antibody. J Neurol Sci. 2014 ; 337 : 55-60.
 
8) Mori M, Kuwabara S, Fukutake T, et al. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001 ; 56 : 1104-6.
PubMed
9) Lyu RK, Tang LM, Cheng SY, et al. Guillain-Barre syndrome in Taiwan : a clinical study of 167 patients. J Neurol Neurosurg Psychiatry. 1997 ; 63 : 494-500.
PubMed
10) Susuki K, Koga M, Hirata K, et al. A Guillain-Barre syndrome variant with prominent facial diplegia. J Neurol. 2009 ; 256 : 1899-905.
PubMed
11) ギラン・バレー症候群, フィッシャー症候群診療ガイドライン作成委員会, 編. ギラン・バレー症候群, フィッシャー症候群 診療ガイドライン 2013. 南江堂 ; 2013.
 
12) 慢性炎症性脱髄性多発根ニューロパチー, 多巣性運動ニューロパチー診療ガイドライン作成委員会, 編. 慢性炎症性脱髄性多発根ニューロパチー, 多巣性運動ニューロパチー診療ガイドライン 2013. 南江堂 ; 2013.
 
13) Ogata H, Yamasaki R. Anti-neurofascin 155 antibody-related neuropathy. Clin Exp Neuroimmunol. 2018 ; 9 : 54-64.
 
14) van Schaik IN, Bril V, van Geloven N, et al. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH) : a randomized, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 2018 ; 17 : 35-46.
PubMed
15) 飯島正博, 祖父江元. CIDPの疫学・症状と神経症候. 日本臨牀. 2015 ; 1085 : 400-7.
 
16) Ogata H, Yamasaki R, Hiwatashi A, et al. Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy. Ann Clin Transl Neurol. 2015 ; 2 : 960-71.
PubMed
17) 千葉厚郎. MAG抗体陽性ニューロパチー. 神経症候群 (第2版) II 別冊日本臨牀. 日本臨牀社 ; 2014. p.851-5.
 
18) Hamada Y, Hirano M, Kuwahara M, et al. Binding specificity of anti-HNK-1 IgM M-protein in anti-MAG neuropathy : Possible clinical relevance. Neurosci Res. 2015 ; 91 : 63-8.
PubMed
19) Zara G, Zambello R, Ermani M. Neurophysiological and clinical responses to rituximab in patients with anti-MAG polyneuropathy. Clin Neurophysiol. 2011 ; 722 : 2518-22.
 
20) Lombardi R, Erne B, Lauria G, et al. IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy. Ann Neurol. 2005 ; 57 : 180-7.
PubMed
21) Stalder AK, Eme B, Reimann R, et al. Immunoglobulin M deposition in cutaneous nerves of anti-myelin-associated glycoprotein polyneuropathy patients correlates with axonal degeneration. J Neuropathol Exp Neurol. 2009 ; 68 : 148-58.
 
P.142 掲載の参考文献
1) Peters MJ, Bakkers M, Merkies IS, et al. Incidence and prevalence of small-fiber neuropathy : a survey in the Netherlands. Neurology. 2013 ; 81 : 1356-60.
PubMed
2) Hoeijmakers JG, Faber CG, Lauria G, et al. Small-fiber neuropathies-advances in diagnosis, pathophysiology and management. Nat Rev Neurol. 2012 ; 8 : 369-79.
 
3) Terkelsen AJ, Karlsson P, Lauria G, et al. The diagnostic challenge of small fiber neuropathy : clinical presentations, evaluations, and causes. Lancet Neurol. 2017 ; 16 : 934-44.
PubMed
4) Farhad K, Traub R, Ruzhansky KM, et al. Causes of neuropathy in patients referred as "idiopathic neuropathy". Muscle Nerve. 2016 ; 53 : 856-61.
PubMed
5) de Greef BT, Hoeijmakers JG, Gorissen-Brouwers CM, et al. Associated conditions in small fiber neuropathy-a large cohort study and review of the literature. Eur J Neurol. 2018 ; 25 : 348-55.
PubMed
6) Bednarik J, Vlckova-Moravcova E, Bursova S, et al. Etiology of small-fiber neuropathy. J Peripher Nerv Syst. 2009 ; 14 : 177-83.
PubMed
7) Anand P, Terenghi G, Warner G, et al. The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med. 1996 ; 2 : 703-7.
PubMed
8) Uceyler N, Kafke W, Riediger N, et al. Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology. 2010 ; 74 : 1806-13.
PubMed
9) Faber CG, Hoeijmakers JG, Ahn HS, et al. Gain of function Nanu 1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol. 2012 ; 71 : 26-39.
 
10) Bakkers M, Faber CG, Hoeijmakers JG, et al. Small fibers, large impact : quality of life in small-fiber neuropathy. Muscle Nerve. 2014 ; 49 : 329-36.
PubMed
11) Lauria G, Dacci P, Lombaridi R, et al. Side and time variability of intraepidermal nerve fiber density. Neurology. 2015 ; 84 : 2368-71.
PubMed
12) Thaisetthawatkul P, Fernandes Filho JA, Herrmann DN. Contribution of QSART to the diagnosis of small fiber neuropathy. Muscle Nerve. 2013 ; 48 : 883-8.
 
13) Bucehr F, Schneider C, Blau T, et al. Small-fiber neuropathy is associated with corneal nerve and dendritic cell alterations : an in vivo confocal microscopy study. Cornea. 2015 ; 34 : 1114-9.
 
14) Ahmed A, Bril V, Orszag A, et al. Detection of diabetic sensorimotor polyneuropathy by corneal confocal microscopy in type 1 diabetes : a concurrent validity study. Diabetes Care. 2012 ; 35 : 821-8.
PubMed
15) Lauria G, Merkies IS, Faber CG. Small fibre neuropathy. Curr Opin Neurol. 2012 ; 25 : 542-9.
PubMed
16) Chan AC, Wilder-Smith EP, et al. Small fiber neuropathy : Getting bigger! Muscle Nerve. 2016 ; 53 : 671-82.
PubMed
17) Smith AG, Russell J, Feldman EL, et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 2006 ; 29 : 1294-9.
PubMed
18) Wakasugi D, Kato T, Gono T, et al. Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren's syndrome. Mod Rheumatol. 2009 ; 19 : 437-40.
 
19) Tavee JO, Karwa K, Ahmed Z, et al. Sarcoidosis-associated small fiber neuropathy in a large cohort : Clinical aspects and response to IVIG and anti-TNF alpha treatment. Respir Med. 2017 ; 126 : 135-8.
 
20) Dabby R, Gilad R, Sadeh M, et al. Acute steroid responsive small-fiber sensory neuropathy : a new entity? J Peripher Nerv Syst. 2006 ; 11 : 47-52.
PubMed
P.148 掲載の参考文献
1) Saghira C, Bis DM, Stanek D, et al. Variant pathogenicity evaluation in the community-driven Inherited Neuropathy Variant Browser. Hum Mutat. 2018 ; 39 : 635-42.
PubMed
2) Juneja M, Burns J, Saporta MA, et al. Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development. J Neurol Neurosurg Psychiatry. 2019 ; 90 : 58-67.
PubMed
3) Kitani-Morii F, Imamura K, Kondo T, et al. Analysis of neural crest cells from Charcot-Marie-Tooth disease patients demonstrates disease-relevant molecular signature. Neuroreport. 2017 ; 28 : 814-21.
PubMed
4) CMT診療マニュアル編集委員会, 編. シャルコー・マリー・トゥース病診療マニュアル 改訂2版. 金芳堂 ; 2015.
 
5) Carter GT, Jensen MP, Galer BS, et al. Neuropathic pain in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil. 1998 ; 79 : 1560-4.
PubMed
6) Miller MJ, Williams LL, Slack SL, et al. The hand in Charcot-Marie-Tooth disease. J Bone Joint Surg. 1991 ; 16 : 191-6.
 
7) 山下敏彦. CMTの痛み・しびれへの対応. CMT診療マニュアル編集委員会, 編. シャルコー・マリー・トゥース病診療マニュアル 改訂2版. 金芳堂 ; 2015. p.103-6.
 
8) Dimitrova EN, Bozinovikj I, Ristovska S, et al. The role of rehabilitation in the management of patients with Charcot-Marie-Tooth disease : report of two cases. Open Access Maced J Med Sci. 2016 ; 4 : 443-8.
PubMed
9) Rose KJ, Raymond J, Refshauge K, et al. Serial night casting increases ankle dorsiflexion range in children and young adults with Charcot-Marie-Tooth disease : a randomised trial. J Physiother. 2010 ; 56 : 113-9.
 
10) Chetlin RD, Mancinelli CA, Gutmann L. Self-reported follow-up post-intervention adherence to resistance exercise training in Charcot-Marie-Tooth disease patients. Muscle Nerve. 2010 ; 42 : 456.
PubMed
11) Lin T, Gibbons P, Mudge AJ, et al. Surgical outcomes of cavovarus foot deformity in children with Charcot-Marie-Tooth disease. Neuromuscul Disord. 2019 ; 29 : 427-36.
PubMed
P.155 掲載の参考文献
1) Sipe JD, Benson MD, Buxbaum JN, et al. Amyloid fibril proteins and amyloidosis : chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid. 2016 ; 23 : 209-13.
PubMed
2) Ando Y, Coelho T, Berk JL, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013 ; 8 : 31.
PubMed
3) 山下太郎, 植田光晴, 安東由喜雄. 遺伝性ATTRアミロイドーシス/トランスサイレチン型家族性アミロイドポリニューロパチー. 安東由喜雄, 植田光晴, 編. アミロイドーシスのすべて-診療ガイドライン 2017とQ&A. 医歯薬出版 ; 2017 : p.32-51.
 
4) Koike H, Tanaka F, Hashimoto R, et al. Natural history of transthyretin Val-30Met familial amyloid polyneuropathy : analysis of late-onset cases from non-endemic areas. J Neurol Neurosurg Psychiatry. 2012 ; 83 : 152-8.
 
5) Gertz MA, Benson MD, Dyck PJ, et al. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol. 2015 ; 66 : 2451-66.
PubMed
6) Ng Wing Tin S, Plante-Bordeneuve V, et al. Characterization of pain in familial amyloid polyneuropathy. J Pain. 2015 ; 16 : 1106-14.
PubMed
7) Masuda T, Ueda M, Suenaga G, et al. Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy. Neurology. 2017 ; 88 : 2192-7.
PubMed
8) Cortese A, Vegezzi E, Lozza A, et al. Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy : avoiding misdiagnosis of a treatable hereditary neuropathy. J Neurol Neurosurg Psychiatry. 2017 ; 88 : 457-8.
PubMed
9) Sekijima Y, Ueda M, Koike H, et al. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan : red-flag symptom clusters and treatment algorithm. Orphanet J Rare Dis. 2018 ; 13 : 6.
PubMed
10) Nakamura M, Yamashita T, Ueda M, et al. Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis. Neurology. 2005 ; 65 : 1051-6.
PubMed
11) Maurer MS, Elliott P, Comenzo R, et al. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circulation. 2017 ; 135 : 1357-77.
PubMed
12) Sekijima Y. Transthyretin (ATTR) amyloidosis : clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry. 2015 ; 86 : 1036-43.
PubMed
13) Kyle RA, Gertz MA. Primary systemic amyloidosis : clinical and laboratory features in 474 cases. Semin Hematol. 1995 ; 32 : 45-59.
PubMed
14) Valleix S, Gillmore JD, Bridoux F, et al. Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin. N Engl J Med. 2012 ; 366 : 2276-83.
 

C 部位によるしびれ感とその対応

P.168 掲載の参考文献
1) 山脇健盛. 部位によるしびれ感とその対応 顔面 三叉神経障害. Clin Neurosci. 2018 ; 36 : 467-71.
 
2) Smith JH, Cutrer FM. Numbness matters : a clinical review of trigeminal neuropathy. Cephalalgia. 2011 ; 31 : 1131-44.
PubMed
3) 中森正博, 山脇健盛. 三叉神経障害とNumb chin症候群. Clin Neurosci. 2012 ; 30 : 556-7.
 
4) 平山惠造, 編. 顔面の感覚障害. 神経症候学改訂第二版 I. 文光堂 ; 2006. p.396-415.
 
5) 山脇健盛. 神経診察総論 神経診察に必要な診察機器. 診断と治療. 2018 ; 106 (Suppl.) : 24-33.
 
6) Ohnuki Y, Mizuma A, Uesugi T, et al. Trigeminal neuropathy accompanied by a pontine lesion on MRI. Intern Med. 2016 ; 55 : 1187-9.
PubMed
7) Di Stefano G, Maarbjerg S, Truini A. Trigeminal neuralgia secondary to multiple sclerosis : from the clinical picture to the treatment options. J Headache Pain. 2019 ; 20 : 20.
 
8) Malhotra A, Tu L, Karla LB, et al. Neuroimaging of Meckel's cave in normal and disease conditions. Insights Imaging. 2018 ; 9 : 499-510.
 
9) Katsura M, Morita A, Horiuchi H, et al. IgG4-related inflammatory pseudotumor of the trigeminal nerve : another component of IgG4-related sclerosing disease? Am J Neuroradiol. 2011 ; 32 : E150-2.
PubMed
10) Sakurai K, Hara M, Okita K, et al. Idiopathic trigeminal neuropathy with trigeminal mass lesion on MRI : Neoplasm or not? Cephalalgia. 2010 ; 30 : 968-74.
PubMed
11) Chen WH. Cheiro-Oral syndrome : a clinical analysis and review of literature. Yonsei Med J. 2009 ; 50 : 777-83.
PubMed
12) Smith RM, Hassan A, Robertson CE. Numb chin syndrome. Curr Pain Headache Rep. 2015 ; 19 : 44.
 
13) 山脇健盛. Numb chin症候群. 成人病と生活習慣病. 2014 ; 44 : 437-41.
Medical*Online
14) Massey EW, Moore J. Mental neuropathy from systemic cancer. Neurology. 1981 ; 31 : 1277-81.
PubMed
15) Galan Gil S, Penarrocha Diago M, Penarrocha Diago M. Malignant mental nerve neuropathy : systematic review. Med Oral Patol Oral Cir Bucal. 2008 ; 13 : E616-21.
PubMed
16) Smith SF, Blackman G, Hopper C. Numb chin syndrome : a nonmetastatic neurological manifestation of malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 ; 105 : e53-6.
PubMed
17) Zadik Y, Benoliel R, Fleissig Y, et al. Painful trigeminal neuropathy induced by oral bisphosphonate-related osteonecrosis of the jaw : a new etiology for the numb-chin syndrome. Quintessence Int. 2012 ; 43 : 97-104.
PubMed
P.176 掲載の参考文献
1) 石塚直樹, 工藤雅子, 寺山靖夫. 【「しびれ感」の多彩な原因とその対応】部位によるしびれ感とその対応 上肢 頸椎症性神経根症, 頸椎症性脊髄症. Clin Neurosci. 2018 ; 36 : 472-5.
 
2) 田中靖久, 国分正一. 頸部神経根症と頸部脊髄症の症候による診断. 越智隆弘, 菊地臣一, 編. NEW MOOK整形外科 No. 6 頸椎症. 金原出版 ; 1999. p.30-8.
 
3) Kokubun S, Sato T, Ishii Y, et al. Cervical myelopathy in the Japanese. Clin Orthop Relat Res. 1996 ; 323 : 129-38.
PubMed
4) Tanaka Y, Kokubun S, Sato T, et al. Cervical roots as origin of pain in the neck or scapular regions. Spine (Phila Pa 1976). 2006 ; 31 : E568-73.
PubMed
5) Pancoast HK. Superior pulmonary sulcus tumor. Tumor characterized by pain, Horner's syndrome, destruction of bone and atrophy of hand muscles. JAMA. 1932 ; 99 : 1391-6.
 
6) Villas C, Collia A, Aquerreta JD, et al. Cervicobrachialgia and pancoast tumor : value of standard anteroposterior cervical radiographs in early diagnosis. Orthopedics. 2004 ; 27 : 1092-5.
PubMed
7) Brodsky AE, Cervical angina. A correlative study with emphasis on the use of coronary arteriography. Spine (Phila Pa 1976). 1985 ; 10 : 699-709.
PubMed
8) Nardin RA, Patel MR, Gudas TF, et al. Electromyography and magnetic resonance imaging in the evaluation of radiculopathy. Muscle Nerve. 1999 ; 22 : 151-5.
PubMed
9) 園生雅弘. 頸椎症と末梢神経障害の鑑別診断-電気生理学的検査を含めて-. Brain Medical. 2013 ; 25 : 49-55.
 
10) Seichi A, Takeshita K, Kawaguchi H, et al. Neurologic level diagnosis of cervical stenotic myelopathy. Spine (Phila Pa 1976). 2006 ; 31 : 1338-43.
PubMed
11) 国分正一. 頸椎症性脊髄症における責任椎間板高位の神経学的診断. 臨床整形外科. 1984 ; 19 : 417-24.
 
12) 小野啓郎. 圧迫性脊髄症の臨床と病理. 日整会誌. 1986 : 60 ; 103-18.
Medical*Online
13) 三原久範. 頸部脊髄症-環・小指にしびれを生じる疾患-. 関節外科. 2016 ; 35 : 776-83.
 
14) Bono CM, Ghiselli G, Gilbert TJ, et al. An evidence-based clinical guideline for the diagnosis and treatment of cervical radiculopathy from degenerative disorders. Spine J. 2011 ; 11 : 64-72.
PubMed
15) Spurling RG, Segerberg LH. Lateral intervertebral disk lesions in the lower cervical region. J Am Med Assoc. 1953 ; 31 : 354-9.
 
16) 日本整形外科学会診療ガイドライン委員会. 頸椎症性脊髄症診療ガイドライン 2015. 南江堂 ; 2007.
 
17) 日本ペインクリニック学会. 末梢神経症の急性炎症による痛み. 神経障害性疼痛薬物療法ガイドライン. 第2版. 真興交易医書出版部 ; 2016.
 
18) 寺山靖夫. しびれ, 痛みの定量的評価. medicina. 2004 ; 41 : 1290-3.
 
19) 工藤雅子, 寺山靖夫. 質問票などによるしびれ・痛みの評価. medicina. 2008 ; 45 : 229-31.
 
20) Terayama Y, Yamamoto M, Honda M, et al. Measurement of quality of life in migraine. Advanced studies in Medicine. 2001 ; 1 : 93-6.
 
P.186 掲載の参考文献
1) 大畑賀央, 宇佐美範恭, 谷口哲郎, 他. 過外転および外旋の術中肢位によると考えられた腕神経損傷の1例. 日本呼外会誌. 2009 ; 23 : 964-8.
 
2) Vander Salm TJ, Cereda JM, Cutler BS. Brachial plexus injury following median sternotomy. J Thorac Cardiovasc Surg. 1980 ; 80 : 447-52.
PubMed
3) 東原真, 園生雅弘, 橋田秀. 症例報告 電気生理学的に局在診断できた胸骨正中切開術後C8腕神経叢障害の1例. 臨床神経学. 2007 ; 47 : 160-4.
 
4) Marchini C, Zambito Marsala S, Cavagna E, et al. Saturday night brachial plexus palsy. Neurol Sci. 2007 ; 28 : 279-81.
PubMed
5) Di Lazzaro V, Giambattistelli F, Pravata E, et al. Brachial palsy after deep sleep. J Neurol Neurosurg Psychiatry. 2014 ; 85 : 1409-10.
PubMed
6) Feinberg JH. Burners and stingers. Phys Med Rehabil Clin N Am. 2000 ; 11 : 771-84.
PubMed
7) Urschel HC Jr. Superior pulmonary sulcus carcinoma. Surg Clin North Am. 1988 ; 68 : 497-509.
PubMed
8) Pierce SM, Recht A, Lingos TI, et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys. 1992 ; 23 : 915-23.
PubMed
9) Yan M, Kong W, Kerr A, et al. The radiation dose tolerance of the brachial plexus : A systematic review and meta-analysis. Clin Transl Radiat Oncol. 2019 ; 18 : 23-31.
PubMed
10) Lederman RJ, Wilbourn AJ. Brachial plexopathy : recurrent cancer or radiation? Neurology. 1984 ; 34 : 1331-5.
PubMed
11) Harper CM Jr, Thomas JE, Cascino TL, et al. Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG. Neurology. 1989 ; 39 : 502-6.
PubMed
12) Delanian S, Lefaix JL, Pradat PF. Radiation-induced neuropathy in cancer survivors. Radiother Oncol. 2012 ; 105 : 273-82.
PubMed
13) van Alfen N, van Engelen BG. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain. 2006 ; 129 (Pt 2) : 438-50.
 
14) Ferrante MA, Wilbourn AJ. Lesion distribution among 281 patients with sporadic neuralgic amyotrophy. Muscle Nerve. 2017 ; 55 : 858-61.
PubMed
15) Sneag DB, Rancy SK, Wolfe SW, et al. Brachial plexitis or neuritis? MRI features of lesion distribution in Parsonage-Turner syndrome. Muscle Nerve. 2018 ; 58 : 359-66.
PubMed
16) ArAnyi Z, Csillik A, DeVay K, et al. Ultrasonography in neuralgic amyotrophy : Sensitivity, spectrum of findings, and clinical correlations. Muscle Nerve. 2017 ; 56 : 1054-62.
PubMed
17) Ferrante MA, Ferrante ND. The thoracic outlet syndromes : Part 1. Overview of the thoracic outlet syndromes and review of true neurogenic thoracic outlet syndrome. Muscle Nerve. 2017 ; 55 : 782-93.
PubMed
18) 園生雅弘, 安藤哲, 内堀歩, 他. True neurogenic thoracic outlet syndrome (TOS) の臨床的・電気生理学的特徴. 臨床神経生理学. 2012 ; 40 : 131-9.
Medical*Online
P.198 掲載の参考文献
1) 菅原正登, 尾鷲和也, 尾山かおり, 他. 胸郭出口症候群の検討 頻度, 症候, 治療成績について. 臨床整形外科. 2006 ; 41 : 637-44.
 
2) 井手淳二. 胸郭出口症候群. 脊椎脊髄ジャーナル. 2011 ; 24 : 487-93.
 
3) Willbourn AJ. Thoracic outlet syndrome. In : Syllabus, Course D : Controversies in entrapment neuropathies. Rochester : American Association of Electromyography and Electrodiagnosis ; 1984. p.28-38.
 
4) 園生雅弘, 安藤哲朗, 内堀歩, 他. True neurogenic thoracic outlet syndrome (TOS) の臨床的・電気生理学的特徴. 臨床神経生理学. 2012 ; 40 : 131-9.
Medical*Online
5) Gilliatt RW, Le Quesne PM, Longue V, et al. Wasting of the hand associated with a cervidal rib or band. J Neurol Neurosurg Psychiatry. 1970 ; 33 : 615-24.
 
6) 井手淳二. 胸郭出口症候群の概念に関する争点. 脊椎脊髄ジャーナル. 2012 ; 25 : 607-11.
 
7) Sevy JO, Dulebohn SC. Carpal tunnel syndrome. StatPearls [Internet]. Treasure Island (FL) : StatPearls Publishing ; 2017.
 
8) Rota E, Morelli N. Entrapment neuropathies in diabetes mellitus. World J Diabetes. 2016 ; 15 : 342-53.
 
9) 安藤哲朗. 頸椎症の診療. 臨床神経学. 2012 ; 52 : 469-79.
 
10) 日本神経治療学会, 監. 標準的神経治療 : 手根管症候群. 2007. https://www.jsnt.gr.jp/guideline/img/syukonkan.pdf
 
11) 野寺裕之. 手根管症候群の電気診断. 臨床神経生理学. 2013 ; 41 : 164-71.
Medical*Online
12) Nagano A. Spontaneous anterior interosseous nerve palsy. J Bone Joint Surg Br. 2003 ; 85 : 313-8.
PubMed
13) Nakashima Y, Sunagawa T, Shinomiya R, et al. High-resolution ultrasonograghic evaluation of "hourglass-like-fasicular contriction" in peripheral nerves : a preliminary report. Ultrasound Med Biol. 2014 ; 40 : 1718-21.
 
14) Nishihara T, Oh SJ. Ulnar neuropathy : an improved method of diagnosis. Arch Phys Med Rehabil. 1976 ; 57 : 602.
 
15) Aleksenko D, Dulebohn SC. Guyon canal syndrome. StatPearls [Internet]. Treasure Island (FL) : StatPearls Publishing ; 2017.
 
16) Ebeling P, Gilliatt RW, Thomas PK. A clinical and electrical study of ulnar nerve lesions in the hand. J Nerurol Neurosurg Psychiatry. 1960 ; 23 : 1-9.
PubMed
17) 北村英二, 濱田潤一, 鈴木康輔, 他. Pure motor isolated syndromeを呈した脳梗塞の1例. 臨床神経学. 2010 ; 50 : 572-7.
 
18) Hashizume H, Nisida K, Nanbu T, et al. Non-traumatic paralysis of the posterior interosseous nerve. J Bone Joint Surg Br. 1996 ; 78 : 771-6.
 
19) Ochi K, Horiuchi Y, Tazaki K, et al. Surgical treatment of spontaneous posterior interosseous nerve palsy : a retrospective study of 50 cases. J Hand Surg Am. 2011 ; 93 : 217-22.
 
20) Suematsu N, Hirayama T. Posterior interosseous nerve palsy. J Hand Surg Br. 1998 ; 23 : 104-6.
PubMed
P.208 掲載の参考文献
1) 日本脊椎脊髄病学会. 脊椎脊髄病用語事典改訂第5版. 南江堂 ; 2015.
 
2) Nagashima M, Abe H, Amaya K, et al. Risk factors for lumbar disc degeneration in high school American football players : a prospective 2-year follow-up study. Am J Sports Med. 2013 ; 41 : 2059-64.
PubMed
3) 松本守雄, 千葉一裕, 戸山芳昭. 【高齢者の腰痛診療】高齢者腰椎椎間板ヘルニアの病態と治療. Orthopaedics. 2009 ; 22 : 53-9
 
4) 岡田英次朗, 浦部忠久, 関口治, 他. 椎体scallopingを呈した腰椎椎間板ヘルニアの1例. 臨床整形外科. 2006 ; 41 : 701-4.
 
5) 細金直文, 松本守雄, 戸山芳昭. 【ロコモティブシンドローム 運動器科学の新時代】主な疾患 腰部椎間板ヘルニアの診断と治療. 医学のあゆみ. 2011 ; 236 : 507-12.
 
6) 千葉一裕, 松本守雄, 石井賢, 他. 【腰・下肢痛の診断と治療】治療 手術 適応と手技 椎間板ヘルニア. 痛みと臨床. 2007 ; 7 : 140-7.
 
7) 奥島雄一郎, 千葉一裕, 松本守雄, 他. 【腰椎椎間板ヘルニアの治療 最近の動向】 ヘルニアの自然経過 ヘルニアの自然縮小 単純MRIによる観察. 骨・関節・靱帯. 2001 ; 14 : 655-8.
 
8) Chiba K, Matsuyama Y, Seo T, et al. Condoliase for the treatment of lumbar disc herniation : a randomized controlled trial. Spine (Phila Pa 1976). 2018 ; 43 : E869-e76.
PubMed
9) 岡田英次朗, 手塚正樹, 柳本繁, 他. 手術手技シリーズ 腰椎椎間板ヘルニアに対する後方内視鏡下手術. Bone Joint Nerve. 2011 ; 1 : 397-401.
 
10) 岡田英次朗, 松本守雄. 【脊椎・脊髄-up to date】脊椎・脊髄疾患と治療 腰椎椎間板ヘルニア 内視鏡下ヘルニア摘出術. Clin Neurosci. 2012 ; 30 : 1138-40.
 
11) 松本守雄, 千葉一裕, 戸山芳昭. 腰椎椎間板ヘルニア治療の最前線 内視鏡下椎間板ヘルニア摘出術 その適応, 利点および問題点. 臨床整形外科. 2007 ; 42 : 209-14.
 
12) North American Spine Society. Diagnosis and Treatment of Degenerative Lumbar Spinal Stenosis. 2011.
PubMed
13) 篠崎義雄, 小川潤, 磯貝宜広, 他. 腰仙椎移行部椎間孔狭窄の病態 腰仙椎椎間孔の形態とL5神経根の走行に着目して. 臨床整形外科. 2015 ; 50 : 509-17.
 
14) 篠崎義雄, 小川潤, 磯貝宜広, 他. 腰仙椎移行部椎間孔狭窄の病態 L5/S1 椎間高位の骨棘の関与. 整形外科. 2014 ; 65 : 1-8.
 
15) 篠崎義雄, 小倉洋二, 小林喜臣, 他. 腰仙椎移行部椎間孔狭窄「症」における椎間孔狭窄・神経根横走の程度と発症因子の検討. J Spine Res. 2018 ; 9 : 1377-82.
Medical*Online
16) Watanabe K, Matsumoto M, Ikegami T, et al. Reduced postoperative wound pain after lumbar spinous process-splitting laminectomy for lumbar canal stenosis : a randomized controlled study. J Neurosurg Spine. 2011 ; 14 : 51-8.
PubMed
17) Watanabe K, Hosoya T, Shiraishi T, et al. Lumbar spinous process-splitting laminectomy for lumbar canal stenosis. Technical note. J Neurosurg Spine. 2005 ; 3 : 405-8.
PubMed
18) 岡田英次朗, 渡辺航太, 松本守雄. 【ロコモの視点を交えた腰部脊柱管狭窄症】棘突起縦割式椎弓切除術. Loco Cure. 2015 ; 1 : 222-7.
 
19) 原田大朗, 松本守雄, 中村雅也, 他. 腰部脊柱管狭窄症手術例における足底部しびれの遺残. 東日本整形災害外科学会雑誌. 2005 ; 17 : 65-8.
Medical*Online
20) Matsumoto M, Watanabe K, Tsuji T, et al. Nocturnal leg cramps : a common complaint in patients with lumbar spinal canal stenosis. Spine (Phila Pa 1976). 2009 ; 34 : E189-94.
PubMed
P.216 掲載の参考文献
1) Parisi TJ, Mandrekar J, Dyck PJ, et al. Meralgia paresthetica : relation to obesity, advanced age, and diabetes mellitus. Neurology. 2011 ; 77 : 1538-42.
PubMed
2) Boyce JR. Meralgia paresthetica and tight trousers. JAMA. 1984 ; 251 : 1553.
PubMed
3) Moucharafieh R, Wehbe J, Maalouf G. Meralgia paresthetica : a result of tight new trendy low cut trousers ('taille basse'). Int J Surg. 2008 ; 6 : 164-8.
PubMed
4) Seror P, Seror R. Meralgia paresthetica : clinical and electrophysiological diagnosis in 120 cases. Muscle Nerve. 2006 ; 33 : 650-4.
PubMed
5) van Slobbe AM, Bohnen AM, Bernsen RM, et al. Incidence rates and determinants in meralgia paresthetica in general practice. J Neurol. 2004 ; 251 : 294-7.
PubMed
6) Boon AJ, Bailey PW, Smith J, et al. Utility of ultrasound-guided surface electrode placement in lateral femoral cutaneous nerve conduction studies. Muscle Nerve. 2011 ; 44 : 525-30.
PubMed
7) Shin YB, Park JH, Kwon DR, et al. Variability in conduction of the lateral femoral cutaneous nerve. Muscle Nerve. 2006 ; 33 : 645-9.
PubMed
8) Benezis I, Boutaud B, Leclerc J, et al. Lateral femoral cutaneous neuropathy and its surgical treatment : a report of 167 cases. Muscle Nerve. 2007 ; 36 : 659-63.
PubMed
9) Hopayian K, Song F, Riera R, et al. The clinical features of the piriformis syndrome : a systematic review. Eur Spine J. 2010 ; 19 : 2095-109.
 
10) Miller TA, White KP, Ross DC. The diagnosis and management of Piriformis syndrome : myths and facts. Can J Neurol Sci. 2012 ; 39 : 577-83.
PubMed
11) Kirschner JS, Foye PM, Cole JL. Piriformis syndrome, diagnosis and treatment. Muscle Nerve. 2009 ; 40 : 10-8.
PubMed
12) Halpin RJ, Ganju A. Piriformis syndrome : a real pain in the buttock? Neurosurgery. 2009 ; 65 : A197-202.
PubMed
13) Hopayian K, Danielyan A. Four symptoms define the piriformis syndrome : an updated systematic review of its clinical features. Eur J Orthop Surg Traumatol. 2018 ; 28 : 155-64.
PubMed
14) Cass SP. Piriformis syndrome : a cause of nondiscogenic sciatica. Curr Sports Med Rep. 2015 ; 14 : 41-4.
PubMed
15) Natsis K, Totlis T, Konstantinidis GA, et al. Anatomical variations between the sciatic nerve and the piriformis muscle : a contribution to surgical anatomy in piriformis syndrome. Surg Radiol Anat. 2014 ; 36 : 273-80.
PubMed
16) Ropper AH, Zafonte RD. Sciatica. N Engl J Med. 2015 ; 372 : 1240-8.
PubMed
17) Jankovic D, Peng P, van Zundert A. Brief review : piriformis syndrome : etiology, diagnosis, and management. Can J Anaesth. 2013 ; 60 : 1003-12.
PubMed
18) Moore AE, Stringer MD. Iatrogenic femoral nerve injury : a systematic review. Surg Radiol Anat. 2011 ; 33 : 649-58.
PubMed
19) Kuntzer T, van Melle G, Regli F. Clinical and prognostic features in unilateral femoral neuropathies. Muscle Nerve. 1997 ; 20 : 205-11.
PubMed
20) Rogers LR, Borkowski GP, Albers JW, et al. Obturator mononeuropathy caused by pelvic cancer : six cases. Neurology. 1993 ; 43 : 1489-92.
PubMed
P.226 掲載の参考文献
1) O'Brien M. Aids to the examination of the peripheral nervous system 5th ed. Saunders Elsevier ; 2010.
 
2) 松崎昭. 伏在神経の絞扼性障害. 骨・関節・靱帯. 1994 ; 7 : 899-905.
 
3) Kopell H, Thompson W. Knee pain due to saphenous-nerve entrapment. N Engl J Med. 1960 ; 263 : 351-3.
 
4) Ducic I, Levin M, Larson EE, et al. Management of chronic leg and knee pain following surgery or trauma related to saphenous nerve and knee neuromata. Ann Plast Surg. 2010 ; 64 : 35-40.
PubMed
5) Bertram C, Porsch M, Hackenbroch MH, et al. Saphenous neuralgia after arthroscopically assisted anterior cruciate ligament reconstruction with a semitendinosus and gracilis tendon graft. Arthroscopy. 2000 ; 16 : 763-6.
PubMed
6) Jaworucka-Kaczorowska A, Oszkinis G, Huber J, et al. Saphenous vein stripping surgical technique and frequency of saphenous nerve injury. Phlebology. 2015 ; 30 : 210-6.
PubMed
7) Mountney J, Wilkinson GA. Saphenous neuralgia after coronary artery bypass grafting. Eur J Cardiothorac Surg. 1999 ; 16 : 440-3.
PubMed
8) Worth RM, Kettelkamp DB, Defalque RJ, et al. Saphenous nerve entrapment. A cause of medial knee pain. Am J Sports Med. 1984 ; 12 : 80-1.
PubMed
9) 松崎昭夫, 高岸直人, 清水万喜夫, 他. 日常外来で経験されるEntrapment Neuropathyについて. 整形外科と災害外科. 1973 ; 22 : 377-9.
 
10) Oh SJ. Clinical electromyography : nerve conduction studies. Lippincott Williams & Wilkins ; 2003.
 
11) Baima J, Krivickas L. Evaluation and treatment of peroneal neuropathy. Curr Rev Musculoskelet Med. 2008 ; 1 : 147-53.
PubMed
12) 正門由. 【臨床ですぐ役立つ 症候からの筋電図検査の組み立て方】下肢の感覚障害と筋力低下 総腓骨神経麻痺を中心に. J Clin Rehabil. 2004 ; 13 : 1098-105.
 
13) 園生雅弘. MMT・針筋電図ガイドブック. 中外医学社 ; 2018. p.206-8.
 
14) Zekry M, Shahban SA, El Gamal T, et al. A literature review of the complications following anterior and posterior ankle arthroscopy. Foot Ankle Surg. 2019 ; 25 : 553-8.
 
15) Kernohan J, Levack B, Wilson JN. Entrapment of the superficial peroneal nerve. Three case reports. J Bone Joint Surg Br. 1985 ; 67 : 60-1.
PubMed
16) Banerjee T, Koons DD. Superficial peroneal nerve entrapment. Report of two cases. J Neurosurg. 1981 ; 55 : 991-2.
 
17) McAuliffe TB, Fiddian NJ, Browett JP. Entrapment neuropathy of the superficial peroneal nerve. A bilateral case. J Bone Joint Surg Br. 1985 ; 67 : 62-3.
 
18) Styf J. Entrapment of the superficial peroneal nerve. Diagnosis and results of decompression. J Bone Joint Surg Br. 1989 ; 71 : 131-5.
PubMed
19) Khalil NM, Nicotra A, Kaplan C, et al. Entrapment of the lateral cutaneous nerve of the calf. BMJ Case Rep. 2013 ; 2013.
PubMed
20) Finelli PF, DiBenedetto M. Bilateral involvement of the lateral cutaneous nerve of the calf in a diabetic. Ann Neurol. 1978 ; 4 : 480-1.
 
P.233 掲載の参考文献
1) 亀山隆. 標準的神経治療 しびれ感. 医学書院 ; 2017 ; 50-5.
 
2) 糸岐一茂, 原田大樹, 千草佳翔, 他. 脊椎脊髄外科におけるMRIの進歩と臨床応用. 整形・災害外科. 2017 ; 60 : 499-508.
 
3) 東原真奈, 園生雅弘. 体性感覚誘発電位. Clin Neurosci. 2016 ; 34 : 801-4.
 
4) Patel AT, Gaines K, Malamut R, et al. Usefulness of electrodiagnostic techniques in the evaluation of suspected tarsal tunnel syndrome : an evidence-based review. Muscle Nerve. 2005 ; 32 : 236-40.
PubMed
5) 中井俊一, 園生雅弘, 所澤安展, 他. 電気生理学的に証明された, 両側副深腓骨神経を併存する前足根管症候群の1例. 臨床神経生理学. 2008 ; 36 : 253-6.
Medical*Online
6) Del Toro DR, Park TA. Abductor hallucis false motor points : electrophysiologic mapping and cadaveric dissection. Muscle Nerve. 1996 ; 19 : 1138-43.
 
7) Oh SJ, Sarala PK, Kuba T, et al. Sensory nerve conduction velocity of the plantar nerves : a superior objective diagnostic test for tarsal tunnel syndrome. Trans Am Neurol Assoc. 1978 ; 103 : 256-8.
PubMed
8) Galardi G, Amadio S, Maderna L, et al. Electrophysiologic studies in tarsal tunnel syndrome. Diagnostic reliability of motor distal latency, mixed nerve and sensory nerve conduction studies. Am J Phys Med Rehabil. 1994 ; 73 : 193-8.
PubMed
9) Guiloff RJ, Sherratt RM. Sensory conduction in medial plantar nerve : normal values, clinical applications, and a comparison with the sural and upper limb sensory nerve action potentials in peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1977 ; 40 : 1168-81.
 
10) Ponsford SN. Sensory conduction in medial and lateral plantar nerves. J Neurol Neurosurg Psychiatry. 1988 ; 51 : 188-91.
PubMed
11) Hemmi S, Kurokawa K, Nagai T, et al. Whole plantar nerve conduction study with disposable strip electrodes. Muscle Nerve. 2016 ; 53 : 209-13.
PubMed
12) Samarawickrama D, Therimadasamy AK, Chan YC, et al. Nerve ultrasound in electrophysiologically verified tarsal tunnel syndrome. Muscle Nerve. 2016 ; 53 : 906-12.
PubMed
13) Aydinlar EI, Uzun M, Beksac B, et al. Simple electrodiagnostic method for Morton neuroma. Muscle Nerve. 2014 ; 49 : 193-7.
PubMed
P.241 掲載の参考文献
1) International Classification of Sleep Disorders 3rd ed. Darien, IL : American Academy of Sleep Medicine ; 2014.
 
2) Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria : updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med. 2014 ; 15 : 860-73.
 
3) Karroum EG, Golmard JL, Leu-Semenescu S, et al. Sensations in restless legs syndrome. Sleep Med. 2012 ; 13 : 402-8.
PubMed
4) Winkelman JW, Gagnon A, Clair AG. Sensory symptoms in restless legs syndrome :the enigma of pain. Sleep Med. 2013 ; 14 : 934-42.
PubMed
5) Karroum EG, Leu-Semenescu S, Arnulf I. Topography of the sensations in primary restless legs syndrome. J Neurol Sci. 2012 ; 320 : 26-31.
PubMed
6) Suzuki K, Suzuki H, Suzuki Y, et al. "Restless face" as a variant of restless legs syndrome. Parkinsonism Relat Disord. 2017 ; 41 : 130-1.
PubMed
7) Turrini A, Raggi A, Calandra-Buonaura G, et al. Not only limbs in atypical restless legs syndrome. Sleep Med Rev. 2018 ; 38 : 50-5.
PubMed
8) Trenkwalder C, Paulus W. Restless legs syndrome : pathophysiology, clinical presentation and management. Nat Rev Neurol. 2010 ; 6 : 337-46.
PubMed
9) 松原健朗, 鈴木圭輔, 岡村穏, 他. 内包後脚梗塞後にrestless shoulderを認めた70歳女性. 臨床神経学. 2017 ; 57 : 711-5.
 
10) Woo HG, Lee D, Hwang KJ, et al. Post-stroke restless leg syndrome and periodic limb movements in sleep. Acta Neurol Scand. 2017 ; 135 : 204-10.
PubMed
11) Shiina T, Suzuki K, Okamura M, et al. Restless legs syndrome and its variants in acute ischemic stroke. Acta Neurol Scand. 2019 ; 139 : 260-8.
PubMed
12) Cho YW, Song ML, Earley CJ, et al. Prevalence and clinical characteristics of patients with restless legs syndrome with painful symptoms. Sleep Med. 2015 ; 16 : 775-8.
PubMed
13) Karroum EG, Golmard JL, Leu-Semenescu S, et al. Painful restless legs syndrome : a severe, burning form of the disease. Clin J Pain. 2015 ; 31 : 459-66.
PubMed
14) Hening W, Walters AS, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population : the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med. 2004 ; 5 : 237-46.
 
15) Suzuki S, Suzuki K, Miyamoto M, et al. Evaluation of contributing factors to restless legs syndrome in migraine patients. J Neurol. 2011 ; 258 : 2026-35.
PubMed
16) Gemignani F, Brindani F, Vitetta F, et al. Restless legs syndrome and painful neuropathy-retrospective study. A role for nociceptive deafferentation? Pain Med. 2009 ; 10 : 1481-6.
PubMed
17) Almeida TF, Roizenblatt S, Tufik S. Afferent pain pathways : a neuroanatomical review. Brain Res. 2004 ; 1000 : 40-56.
PubMed
18) Laverdure-Dupont D, Lavigne G, Montplaisir J, et al. Is the Manifestation of the restless legs syndrme related to a pain mechanism? In : Hening WA, Allen RP, Chokroverty S, eds. Restless legs syndrome. Philadelphia : Saunders ; 2009 : 206-18.
 
19) Stiasny-Kolster K, Pfau DB, Oertel WH, et al. Hyperalgesia and functional sensory loss in restless legs syndrome. Pain. 2013 ; 154 : 1457-63.
PubMed
20) Stiasny-Kolster K, Magerl W, Oertel WH, et al. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain. 2004 ; 127 : 773-82.
PubMed
21) Lim YM, Chang SE, Chung S, et al. Small fiber function in drug naive patients with idiopathic restless legs syndrome. J Clin Neurosci. 2012 ; 19 : 702-5.
 
22) Polydefkis M, Allen RP, Hauer P, et al. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology. 2000 ; 55 : 1115-21.
PubMed
23) Dafkin C, McKinon W, Kerr S. Restless legs syndrome : clinical changes in nervous system excitability at the spinal cord level. Sleep Med Rev. 2019 ; 47 : 9-17.
PubMed
24) Bucher SF, Seelos KC, Oertel WH, et al. Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol. 1997 ; 41 : 639-45.
PubMed
25) Etgen T, Draganski B, Ilg C, et al. Bilateral thalamic gray matter changes in patients with restless legs syndrome. Neuroimage. 2005 ; 24 : 1242-7.
PubMed
26) Schattschneider J, Bode A, Wasner G, et al. Idiopathic restless legs syndrome : abnormalities in central somatosensory processing. J Neurol. 2004 ; 251 : 977-82.
PubMed
27) von Spiczak S, Whone AL, Hammers A, et al. The role of opioids in restless legs syndrome : an [11C] diprenorphine PET study. Brain. 2005 ; 128 : 906-17.
PubMed
28) Wijemanne S, Ondo W. Restless legs syndrome : clinical features, diagnosis and a practical approach to management. Pract Neurol. 2017 ; 17 : 444-52.
 
29) Garcia-Borreguero D, Cano-Pumarega I. New concepts in the management of restless legs syndrome. BMJ. 2017 ; 356 : j104.
 
30) Garcia-Borreguero D, Cano I, Granizo JJ. Treatment of restless legs syndrome with the selective AMPA receptor antagonist perampanel. Sleep Med. 2017 ; 34 : 105-8.
PubMed
31) Wanner V, Garcia Malo C, Romero S, et al. Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome. Adv Pharmacol. 2019 ; 84 : 187-205.
PubMed
32) Ramachandran VS, Hirstein W. The perception of phantom limbs. The D. O. Hebb lecture. Brain. 1998 ; 121 (Pt 9) : 1603-30.
 
33) Vetrugno R, Alessandria M, D'Angelo R, et al. "Phantom" restless legs syndrome. J Neurol Neurosurg Psychiatry. 2010 ; 81 : 122-3.
PubMed
34) Nishida S, Hitsumoto A, Namba K, et al. Persistence of secondary restless legs syndrome in a phantom limb caused by end-stage renal disease. Intern Med. 2013 ; 52 : 815-8.
 
35) Giummarra MJ, Bradshaw JL. The phantom of the night : restless legs syndrome in amputees. Med Hypotheses. 2010 ; 74 : 968-72.
PubMed

書評

最近チェックした商品履歴

Loading...